Latest papers

Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.

A Korean family of familial medullary thyroid cancer with Cys618Ser RET germline mutation.

Current management of medullary thyroid cancer.

Medullary thyroid carcinoma, small cell variant, as a diagnostic challenge on fine needle aspiration: a case report.

[Multiple endocrine neoplasia: genetic aspects].

Does percutaneous thyroid laser ablation induce mixed papillary and medullary thyroid carcinoma?

[Micromedullary thyroid carcinoma: school experience].

[Clinical characteristics of multiple endocrine neoplasia]

[BRCA1- and BRCA2- associated breast carcinomas].

Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis.

MR imaging findings of benign and malignant circumscribed breast masses: part 1. Solid circumscribed masses.

Targeted molecular therapies in thyroid carcinoma.

Significance of Marginally Elevated Calcitonin Levels in Micromedullary Thyroid Cancer

[The treatment of medullary thyroid cancer].

Radioiodinated metaiodobenzylguanidine treatment of neuroendocrine tumors in adults.

Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.

A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.

When Is Prophylactic Thyroidectomy Indicated for Patients with the RET Codon 609 Mutation?

New directions in the systemic treatment of metastatic thyroid cancer.